It is known that elevated inflammation through secretion of inflammatory mediators, such as interleukin (IL)-6, IL-8, IL-1β, tumor necrosis factor (TNF)-α and activation of nuclear factor (NF)-κB promotes the occurrence and development of NAFLD [7]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.